1) Alonso J, Lepine JP, Committee ESMS:Overview of key data from the European Study of the Epidemiology of Mental Disorders(ESEMeD). J Clin Psychiatry 68(Suppl 2):3-9, 2007
2) Bandelow B, Lichte T, Rudolf S, et al:The diagnosis of and treatment recommendations for anxiety disorders. Dtsch Arztebl Int 111:473-480, 2014
3) Bourdon KH, Rae DS, Locke BZ, et al:Estimating the prevalence of mental disorders in U.S. adults from the Epidemiologic Catchment Area Survey. Public Health Rep 107:663-668, 1992
4) Buckley PF, Miller BJ, Lehrer DS, et al:Psychiatric comorbidities and schizophrenia. Schizophr Bull 35:383-402, 2009
5) Dilsaver SC, Benazzi F, Akiskal KK, et al:Differential patterns of lifetime multiple anxiety disorder comorbidity between Latino adults with bipolar I and major depressive disorders. Bull Menninger Clin 72:130-148, 2008
6) Duffy A, Alda M, Hajek T, et al:Early stages in the development of bipolar disorder. J Affect Disord 121:127-135, 2010
7) 学校法人慶應義塾:平成22年度厚生労働省障害者福祉総合推進事業補助金「精神疾患の社会的コストの推計」事業実績報告書.2011
8) 板山稔,高田絵理子,児玉有子,他:青森県の小・中・高校におけるメンタルヘルス問題と精神保健教育の現状に関する調査研究.弘前医療福祉大学紀要 5:59-67, 2014
9) 川上憲人:こころの健康についての疫学調査に関する研究.平成18年度厚生労働科学研究費補助金(こころの健康科学研究事業)統括研究報告書.2007
10) Kessler RC, McGonagle KA, Zhao S, et al:Lifetime and 12-month prevalence of DSM-Ⅲ-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19, 1994
11) Kessler RC, Chiu WT, Demler O, et al:Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:617-627, 2005
12) Kessler RC, Avenevoli S, Costello EJ, et al:Prevalence, persistence, and sociodemographic correlates of DSM-Ⅳ disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry 69:372-380, 2012
13) Lamers F, van Oppen P, Comijs HC, et al:Comorbidity patterns of anxiety and depressive disorders in a large cohort study:The Netherlands Study of Depression and Anxiety(NESDA). J Clin Psychiatry 72:341-348, 2011
14) Lim J, Rekhi G, Rapisarda A, et al:Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis-Findings from the Longitudinal Youth at Risk Study(LYRIKS). Schizophr Res 164:8-14, 2015
15) 松原達哉:UPI学生精神的健康調査.松原達哉,編著:心理テスト法入門第4版—基礎知識と技法習得のために.日本文化科学社,pp177-179, 2002
16) Michail M, Birchwood M:Social anxiety disorder in first-episode psychosis:Incidence, phenomenology and relationship with paranoia. Br J Psychiatry 195:234-241, 2009
17) Muramatsu K, Miyaoka H, Kamijima K, et al:The patient health questionnaire, Japanese version:Validity according to the mini-international neuropsychiatric interview-plus. Psychol Rep 101:952-960, 2007
18) Olatunji BO, Cisler JM, Tolin DF:Quality of life in the anxiety disorders:A meta-analytic review. Clin Psychol Rev 27:572-581, 2007
19) Pavlova B, Perlis RH, Alda M, et al:Lifetime prevalence of anxiety disorders in people with bipolar disorder:A systematic review and meta-analysis. Lancet Psychiatry 2:710-717, 2015
20) Rhebergen D, Batelaan NM, de Graaf R, et al:The 7-year course of depression and anxiety in the general population. Acta Psychiatr Scand 123:297-306, 2011
21) Simon NM, Otto MW, Wisniewski SR, et al:Anxiety disorder comorbidity in bipolar disorder patients:Data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder(STEP-BD). Am J Psychiatry 161:2222-2229, 2004
22) 財団法人日本学校保健会:子どものメンタルヘルスの理解とその対応—心の健康つくりの推進に向けた組織体制づくりと連携.財団法人日本学校保健会,2007